Does geographic location impact the survival differential between screen- and interval-detected breast cancers?

Stochastic Environmental Research and Risk Assessment

Volumn 30, Issue 1, 2016, Pages 155-165

  Hsieh, Jeff Ching Fu ^a   Cramb, Susanna M ^b   McGree, James M ^a   Dunn, Nathan A M ^c   Baade, Peter D ^b   Mengersen, Kerrie L ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b CANCER COUNCIL QUEENSLAND   (Australia)

^c Preventive Health Unit   (Australia)

Author keywords

Bayesian modelling; Breast cancer; Interval detected; Mammography screening; Relative survival; Spatial survival inequalities

Indexed keywords

DIAGNOSIS; MARKOV PROCESSES; MONTE CARLO METHODS; RISK ASSESSMENT; TUMORS;

BAYESIAN MODELLING; BREAST CANCER; INTERVAL-DETECTED; MAMMOGRAPHY SCREENING; RELATIVE SURVIVAL; SPATIAL SURVIVAL INEQUALITIES;

DISEASES;

BAYESIAN ANALYSIS; CANCER; DETECTION METHOD; DISEASE TREATMENT; GEOGRAPHICAL VARIATION; HEALTH GEOGRAPHY; HEALTH RISK; MORTALITY; SURVIVAL; WOMENS HEALTH;

AUSTRALIA; QUEENSLAND;

EID: 84958169315     PISSN: 14363240     EISSN: 14363259     Source Type: Journal    
DOI: 10.1007/s00477-015-1050-4     Document Type: Article

References (56)

1. Australian Bureau of Statistics (2008) Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2006. Cat. No. 2033.0.55.001, ABS, Canberra
2. Australian Institute of Health and Welfare (2004) Rural, regional and remote health: a guide to remoteness classifications. Cat. No. PHE 53, AIHW, Canberra
3. Australian Institute of Health and Welfare (2013) BreastScreen Australia monitoring report 2010–2011. Cancer series no. 77. Cat. no. CAN 74, AIHW, Canberra
4. Australian Institute of Health and Welfare, Cancer Australia and Australasian Association of Cancer Registries (2008) Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer series no.55. Cat.no. CAN 51, AIHW, Canberra
5. Baade P, Turrell G, Aitken J (2011) Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional, multilevel study. J Epidemiol Community Health 65:1037–1043
6. Berry D, Cronin K, Plevritis S, Fryback D, Clarke L, Zelen M, Mandelblatt J, Yakovlev A, Habbema J, Feuer E (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792
7. Besag J, York J, Mollie A (1991) Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math 43(1):1–20
8. Bordas P, Jonsson H, Nystrm L, Lenner P (2007) Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden. Breast 16(1):47–54
9. Brekelmans C, Peeters P, Deurenberg J, Collette H (1995) Survival in interval breast cancer in the DOM screening programme. Eur J Cancer 31:1830–1835
10. Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ (1996) Histopathology and growth rate of interval breast carcinoma: characterization of different subgroups. Cancer 78:1220–1228
11. Brenner H, Hakulinen T (2002) Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 20(3):826–832
12. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, nad M L Gjerstorff LM, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377:127–138
13. Coughlin SS, Thompson TD, Hall HI, Logan P, Uhler RJ (2002) Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998–1999. Cancer 94(11):2801–2812
14. Cramb SM, Mengersen KL, Baade PD (2011) Developing the atlas of cancer in Queensland: methodological issues. Int J Health Geogr 10:9. doi:10.1186/1476-072X-10-9
15. Cramb SM, Mengersen KL, Turrell G, Baade PD (2012) Spatial inequalities in colorectal and breast cancer survival: premature deaths and associated factors. Health Place 18:1412–1421
16. Dahlui M, Ng C, Sadat NA, Ismail S, Bulgiba A (2011) Is breast self examination (BSE) still relevant? A study on BSE performance among female staff of University of Malaya. Asian Pac J Cancer Prev 12:369–372
17. Dasgupta P, Baade P, Aitken J, Turrell G (2012) Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage. Breast Cancer Res Treat 132(2):701–710
18. Davies EA, Renshaw C, Dixon S, Mller H, Coupland VH (2013) Socioeconomic and ethnic inequalities in screen-detected breast cancer in London. J Public Health 1–9. doi:10.1093/pubmed/fdt002
19. Dickman P, Sloggett A, Hills M, Hakulinen T (2004) Regression models for relative survival. Stat Med 23(1):51–64
20. Eberly LE, Carlin BP (2000) Identifiability and convergence issues for Markov chain Monte Carlo fitting of spatial models. Stat Med 19:2279–2294
21. Ederer F, Heise H (1959) Instructions to IBM 650 programmers in processing survival computations (No. 10) p Methodological note, End Results Evaluation Section, National Cancer Institute, Bethesda, MD
22. Ellison LF, Gibbons L (2006) Survival from cancer-up-to-date predictions using period analysis. Health Rep 17(2):19–30
23. Eriksson L, Czene K, Rosenberg LU, Trnberg S, Humphreys K, Hall P (2013) Mammographic density and survival in interval breast cancers. Breast Cancer Res 15:R48. doi:10.1186/bcr3440
24. Fairley L, Forman D, West R, Manda S (2008) Spatial variation in prostate cancer survival in the Northern and Yorkshire region of England using Bayesian relative survival smoothing. Br J Cancer 99(11):1786–1793
25. Gelman A, Rubin D (1992) Inference from iterative simulation using multiple sequences. Stat Sci 7(4):457–472
26. Gelman A, Carlin J, Stern H, Rubin D (2014) Bayesian data analysis, 2nd edn. Chapman & Hall/CRC, London
27. Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR (2000) Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 92(9):743–749
28. Goovaerts P (2006) Geostatistical analysis of disease data: accounting for spatial support and population density in the isopleth mapping of cancer mortality risk using area-to-point Poisson kriging. Int J Health Geogr 5(52):31
29. Haining R, Law J, Maheswaran R, Pearson T, Brindley P (2007) Bayesian modelling of environmental risk: example using a small area ecological study of coronary heart disease mortality in relation to modelled outdoor nitrogen oxide levels. Stoch Environ Res Risk Assess 21:501–509
30. Hofvind S, Geller B, Skaane P (2008) Mammographic features and histopathological findings of interval breast cancers. Acta Radiol 49(9):975–981
31. Hsieh JCF, Cramb SM, McGree JM, Baade PD, Dunn NAM, Mengersen KL (2014) Bayesian spatial analysis for the evaluation of breast cancer detection method. Aust N Z J Stat 55:351–367
32. Kavanagh A, Amos AF, Mark GM (1999) The Ascertainment and reporting of interval cancers within the breast screen Australian program. NHMRC NBCC, Sydney
33. Liao YL, Wang JF, Wu JL, Wang JJ, Zheng XY (2011) A comparison of methods for spatial relative risk mapping of human neural tube defects. Stoch Environ Res Risk Assess 25:99–106
34. Lunn D, Thomas A, Best N, Spiegelhalter D (2000) WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 10:325–337
35. Lustria MLA, Kazmer MM, Glueckauf RL, Hawkins RP, Randeree E, Rosario IB, McLaughlin C, Redmond S (2010) Participatory design of a health informatics system for rural health practitioners and disadvantaged women. J Assoc Inf Sci Technol 61(11):2243–2255
36. Ma I, Dueck A, Gray R, Wasif N, Giurescu M, Lorans R, Pizzitola V, Pockaj B (2012) Clinical and self breast examination remain important in the Era of modern screening. Ann Surg Oncol 19:1484–1490
37. McKenzie F, Ives A, Jeffreys M (2012) Socio-economic inequalities in survival from screen-detected breast cancer in South West England: population-based cohort study. Eur J Public Health 22:418–422
38. McLafferty S, Wang F, Luo L, Butler J (2011) Rural—urban inequalities in late-stage breast cancer: spatial and social dimensions of risk and access. Environ Plann B Plann Des 38(4):724–740
39. Mook S, Veer LV, Rutgers E, Ravdin P, van de Velde A, van Leeuwen F, Visser O, Schmidt M (2011) Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst 103(7):585–597
40. Nagtegaal I, Allgood P, Duffy S, Kearins O, Sullivan E, Tappenden N, Wallis M, Lawrence G (2011) Prognosis and pathology of screen detected carcinomas. Cancer 117:1360–1368
41. Nelson AL (2013) Controversies regarding mammography, breast self-examination, and clinical breast examination. Obstet Gynecol Clin North Am 40:413–427
42. Pohar M, Stare J (2006) Relative survival analysis in R. Comput Methods Programs Biomed 81:272–278
43. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91:2020–2028
44. Puigpins-Riera R, Mar-Dell’Olmo M, Gotsens M, Borrell C, Serral G, Ascaso C, Calvo M, Daponte A, Domnguez-Berjn F, Esnaola S (2011) Cancer mortality inequalities in urban areas: a Bayesian small area analysis in Spanish cities. Int J Health Geogr 10(1):6
45. R Development Core Team (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org/
46. Rayson D, Payne JI, Abdolell M, Barnes PJ, MacIntosh RF, Foley T, Younis T, Burns A, Caines J (2011) Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a canadian breast screening program: a nested case-control study. Clin Breast Cancer 11(1):27–32
47. Saez M, Barcel M, Martos C, Saurina C, Marcos-Gragera R, Renart G, Ocaa-Riola R, Feja C, Alcal T (2012) Spatial variability in relative survival from female breast cancer. J R Stat Soc Ser A Stat Soc 175:107–134
48. Shen Y, Yang Y, Inoue L, Munsell M, Miller A, Berry D (2005) Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 97(16):1195–1203
49. StataCorp (2013) Stata Statistical Software: Release 13. StataCorp LP, College Station, TX
50. Tango T (2000) A test for spatial disease clustering adjusted for multiple testing. Stat Med 19:191–204
51. Ugarte MD, Ibez B, Militino AF (2005) Detection of spatial variation in risk when using CAR models for smoothing relative risks. Stoch Environ Res Risk Assess 19:33–40
52. Wakefield J (2007) Disease mapping and spatial regression with count data. Biostatistics 8(2):158–183
53. Warren R, Duffy S (2000) Interval cancers as an indicator of perfomance in breast screening. Breast Cancer 7:9–18
54. Wilke LG, Broadwater G, Rabiner S, Owens E, Yoon S, Ghate S, Scott V, Walsh R, Baker J, Soo MS, Ibarra-Drendall C, Stouder A, Robertson S, Barron A, Seewaldt V (2009) Breast self-examination: defining a cohort still in need. Am J Surg 198:575–579
55. Wu J, Anttila A, Yen A, Hakama M, Saarenmaa I, Sarkeala T, Malila N, Auvinen A, Chiu S, Chen T (2010) Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region. Breast Cancer Res Treat 121(3):671–678
56. Youlden D, Cramb S, Baade P (2009) Current status of female breast cancer in Queensland, 1982–2006. Viertel Centre for Research in Cancer Control, Cancer Council Queensland